T1	AdverseReaction 52 63	Anaphylaxis
T2	AdverseReaction 68 78	angioedema
T3	AdverseReaction 152 194	Progressive multifocal leukoencephalopathy
T4	AdverseReaction 196 199	PML
T5	AdverseReaction 284 295	Lymphopenia
T6	AdverseReaction 610 621	anaphylaxis
T7	AdverseReaction 626 636	angioedema
T8	AdverseReaction 724 744	difficulty breathing
T9	AdverseReaction 746 755	urticaria
T10	AdverseReaction 761 783	swelling of the throat
T11	AdverseReaction 761 776;788 794	swelling of the tongue
T12	AdverseReaction 1036 1078	progressive multifocal leukoencephalopathy
T13	AdverseReaction 1080 1083	PML
T19	AdverseReaction 1449 1460	lymphopenia
T20	AdverseReaction 1603 1614	lymphopenia
T21	AdverseReaction 2391 2417	decrease lymphocyte counts
T22	Factor 2387 2390	may
T23	AdverseReaction 2461 2488	lymphocyte counts decreased
T24	AdverseReaction 2857 2867	infections
T25	AdverseReaction 2893 2903	infections
T26	AdverseReaction 3001 3010;3032 3042	increased infections
T27	AdverseReaction 3194 3197	PML
T28	AdverseReaction 3216 3237	prolonged lymphopenia
T29	AdverseReaction 4471 4479	flushing
T30	AdverseReaction 4487 4493	warmth
T31	AdverseReaction 4495 4502	redness
T32	AdverseReaction 4504 4511	itching
T33	AdverseReaction 4520 4537	burning sensation
T34	AdverseReaction 4606 4614	flushing
T35	AdverseReaction 4616 4624	Flushing
T36	AdverseReaction 4770 4778	flushing
T37	Severity 4787 4791	mild
T38	Severity 4795 4803	moderate
T39	AdverseReaction 4875 4883	flushing
T40	AdverseReaction 4904 4912	flushing
T41	Factor 600 603	can
T42	AdverseReaction 1022 1027	fatal
T14	Severity 1439 1448	prolonged
T15	AdverseReaction 2767 2799	lymphocyte counts <0.5x10  9  /L
T16	Severity 2885 2892	serious
T17	Negation 2998 3000	no
T18	Severity 3024 3031	serious
T43	AdverseReaction 3420 3454	lymphocyte counts <0.5 x 10  9  /L
T44	AdverseReaction 3515 3532;3542 3556	lymphocyte counts <0.5x10  9  /L
T45	Severity 4896 4903	serious
T46	Severity 4932 4952	not life-threatening
T47	AdverseReaction 5047 5055	flushing
T48	AdverseReaction 5219 5227	flushing
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6 Hypothetical:E41
E7	AdverseReaction:T7 Hypothetical:E41
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E19	AdverseReaction:T19 Effect:E14
E20	AdverseReaction:T20
E21	AdverseReaction:T21 Hypothetical:E22
E22	Factor:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25 Effect:E16
E26	AdverseReaction:T26 Effect:E18 Negated:E17
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T34
E35	AdverseReaction:T35
E36	AdverseReaction:T36 Effect:E37 Effect2:E38
E37	Severity:T37
E38	Severity:T38
E39	AdverseReaction:T39
E40	AdverseReaction:T40 Effect:E45 Effect2:E46
E41	Factor:T41
E42	AdverseReaction:T42
E14	Severity:T14
E15	AdverseReaction:T15
E16	Severity:T16
E17	Negation:T17
E18	Severity:T18
E43	AdverseReaction:T43
E44	AdverseReaction:T44
E45	Severity:T45
E46	Severity:T46
E47	AdverseReaction:T47
E48	AdverseReaction:T48
A1	CUI E1 C0002792
A2	UMLS-Preferred-Name E1 anaphylaxis
A3	MEDDRA-PT E1 Anaphylactic reaction
A4	MEDDRA-PT-ID E1 10002198
A5	LLT E1 Anaphylaxis
A6	LLT-ID E1 10002218
A7	CUI E2 C0002994
A8	UMLS-Preferred-Name E2 Angioedema
A9	MEDDRA-PT E2 Angioedema
A10	MEDDRA-PT-ID E2 10002424
A11	CUI E3 C0023524
A12	UMLS-Preferred-Name E3 Leukoencephalopathy, Progressive Multifocal
A13	MEDDRA-PT E3 Progressive multifocal leukoencephalopathy
A14	MEDDRA-PT-ID E3 10036807
A15	CUI E4 C0023524
A16	UMLS-Preferred-Name E4 Leukoencephalopathy, Progressive Multifocal
A17	MEDDRA-PT E4 Progressive multifocal leukoencephalopathy
A18	MEDDRA-PT-ID E4 10036807
A19	CUI E5 C0024312
A20	UMLS-Preferred-Name E5 Lymphopenia
A21	MEDDRA-PT E5 Lymphopenia
A22	MEDDRA-PT-ID E5 10025327
A23	CUI E6 C0002792
A24	UMLS-Preferred-Name E6 anaphylaxis
A25	MEDDRA-PT E6 Anaphylactic reaction
A26	MEDDRA-PT-ID E6 10002198
A27	LLT E6 Anaphylaxis
A28	LLT-ID E6 10002218
A29	CUI E7 C0002994
A30	UMLS-Preferred-Name E7 Angioedema
A31	MEDDRA-PT E7 Angioedema
A32	MEDDRA-PT-ID E7 10002424
A33	CUI E8 C0013404
A34	UMLS-Preferred-Name E8 Dyspnea
A35	MEDDRA-PT E8 Dyspnoea
A36	MEDDRA-PT-ID E8 10013968
A37	LLT E8 Difficulty breathing
A38	LLT-ID E8 10012791
A39	CUI E9 C0042109
A40	UMLS-Preferred-Name E9 Urticaria
A41	MEDDRA-PT E9 Urticaria
A42	MEDDRA-PT-ID E9 10046735
A43	CUI E10 C0559687
A44	UMLS-Preferred-Name E10 Congestion of throat
A45	MEDDRA-PT E10 Pharyngeal oedema
A46	MEDDRA-PT-ID E10 10034829
A47	LLT E10 Throat swelling
A48	LLT-ID E10 10043525
A49	CUI E11 C0236068
A50	UMLS-Preferred-Name E11 Tongue swelling
A51	MEDDRA-PT E11 Swollen tongue
A52	MEDDRA-PT-ID E11 10042727
A53	LLT E11 Swelling of tongue
A54	LLT-ID E11 10042706
A55	CUI E12 C0023524
A56	UMLS-Preferred-Name E12 Leukoencephalopathy, Progressive Multifocal
A57	MEDDRA-PT E12 Progressive multifocal leukoencephalopathy
A58	MEDDRA-PT-ID E12 10036807
A59	CUI E13 C0023524
A60	UMLS-Preferred-Name E13 Leukoencephalopathy, Progressive Multifocal
A61	MEDDRA-PT E13 Progressive multifocal leukoencephalopathy
A62	MEDDRA-PT-ID E13 10036807
A63	CUI E19 C0024312
A64	UMLS-Preferred-Name E19 Lymphopenia
A65	MEDDRA-PT E19 Lymphopenia
A66	MEDDRA-PT-ID E19 10025327
A67	CUI E20 C0024312
A68	UMLS-Preferred-Name E20 Lymphopenia
A69	MEDDRA-PT E20 Lymphopenia
A70	MEDDRA-PT-ID E20 10025327
A71	CUI E21 C0853986
A72	UMLS-Preferred-Name E21 Lymphocyte count decreased
A73	MEDDRA-PT E21 Lymphocyte count decreased
A74	MEDDRA-PT-ID E21 10025256
A75	CUI E23 C0853986
A76	UMLS-Preferred-Name E23 Lymphocyte count decreased
A77	MEDDRA-PT E23 Lymphocyte count decreased
A78	MEDDRA-PT-ID E23 10025256
A79	CUI E24 C3714514
A80	UMLS-Preferred-Name E24 Infection
A81	MEDDRA-PT E24 Infection
A82	MEDDRA-PT-ID E24 10021789
A83	CUI E25 C3714514
A84	UMLS-Preferred-Name E25 Infection
A85	MEDDRA-PT E25 Infection
A86	MEDDRA-PT-ID E25 10021789
A87	CUI E26 C0236171
A88	UMLS-Preferred-Name E26 Increased susceptibility to infections
A89	MEDDRA-PT E26 Infection susceptibility increased
A90	MEDDRA-PT-ID E26 10021866
A91	CUI E27 C0023524
A92	UMLS-Preferred-Name E27 Leukoencephalopathy, Progressive Multifocal
A93	MEDDRA-PT E27 Progressive multifocal leukoencephalopathy
A94	MEDDRA-PT-ID E27 10036807
A95	flag E28 underspecified
A96	CUI E28 C0024312
A97	UMLS-Preferred-Name E28 Lymphopenia
A98	MEDDRA-PT E28 Lymphopenia
A99	MEDDRA-PT-ID E28 10025327
A100	CUI E29 C0016382
A101	UMLS-Preferred-Name E29 Flushing
A102	MEDDRA-PT E29 Flushing
A103	MEDDRA-PT-ID E29 10016825
A104	CUI E30 C0549386
A105	UMLS-Preferred-Name E30 Sensation of warmth
A106	MEDDRA-PT E30 Feeling hot
A107	MEDDRA-PT-ID E30 10016334
A108	LLT E30 Warmth
A109	LLT-ID E30 10047824
A110	CUI E31 C0332575
A111	UMLS-Preferred-Name E31 Redness
A112	MEDDRA-PT E31 Erythema
A113	MEDDRA-PT-ID E31 10015150
A114	LLT E31 Redness
A115	LLT-ID E31 10038198
A116	CUI E32 C0033774
A117	UMLS-Preferred-Name E32 Pruritus
A118	MEDDRA-PT E32 Pruritus
A119	MEDDRA-PT-ID E32 10037087
A120	LLT E32 Itching
A121	LLT-ID E32 10023084
A122	CUI E33 C0085624
A123	UMLS-Preferred-Name E33 Burning sensation
A124	MEDDRA-PT E33 Burning sensation
A125	MEDDRA-PT-ID E33 10006784
A126	CUI E34 C0016382
A127	UMLS-Preferred-Name E34 Flushing
A128	MEDDRA-PT E34 Flushing
A129	MEDDRA-PT-ID E34 10016825
A130	CUI E35 C0016382
A131	UMLS-Preferred-Name E35 Flushing
A132	MEDDRA-PT E35 Flushing
A133	MEDDRA-PT-ID E35 10016825
A134	CUI E36 C0016382
A135	UMLS-Preferred-Name E36 Flushing
A136	MEDDRA-PT E36 Flushing
A137	MEDDRA-PT-ID E36 10016825
A138	CUI E39 C0016382
A139	UMLS-Preferred-Name E39 Flushing
A140	MEDDRA-PT E39 Flushing
A141	MEDDRA-PT-ID E39 10016825
A142	CUI E40 C0016382
A143	UMLS-Preferred-Name E40 Flushing
A144	MEDDRA-PT E40 Flushing
A145	MEDDRA-PT-ID E40 10016825
A146	CUI E42 C1306577
A147	UMLS-Preferred-Name E42 Death (finding)
A148	MEDDRA-PT E42 Death
A149	MEDDRA-PT-ID E42 10011906
A150	CUI E15 C0853986
A151	UMLS-Preferred-Name E15 Lymphocyte count decreased
A152	MEDDRA-PT E15 Lymphocyte count decreased
A153	MEDDRA-PT-ID E15 10025256
A154	LLT E15 Lymphocyte count low
A155	LLT-ID E15 10025259
A156	CUI E43 C0853986
A157	UMLS-Preferred-Name E43 Lymphocyte count decreased
A158	MEDDRA-PT E43 Lymphocyte count decreased
A159	MEDDRA-PT-ID E43 10025256
A160	LLT E43 Lymphocyte count low
A161	LLT-ID E43 10025259
A162	CUI E44 C0853986
A163	UMLS-Preferred-Name E44 Lymphocyte count decreased
A164	MEDDRA-PT E44 Lymphocyte count decreased
A165	MEDDRA-PT-ID E44 10025256
A166	LLT E44 Lymphocyte count low
A167	LLT-ID E44 10025259
A168	CUI E47 C0016382
A169	UMLS-Preferred-Name E47 Flushing
A170	MEDDRA-PT E47 Flushing
A171	MEDDRA-PT-ID E47 10016825
A172	CUI E48 C0016382
A173	UMLS-Preferred-Name E48 Flushing
A174	MEDDRA-PT E48 Flushing
A175	MEDDRA-PT-ID E48 10016825
